ClinicalTrials.gg

Provention Bio, Inc. clinical trials

Acquired by Sanofi, Apr 27, 2023 · source ↗

The registry lists 9 studies whose lead sponsor is Provention Bio, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 3, 2026.

Before and after it joined Sanofi

First submitted before Provention Bio, Inc. became part of Sanofi
9
First submitted after Provention Bio, Inc. became part of Sanofi
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Provention Bio, Inc.’s studies test, most studies first; none is open now — 2 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

1 of Provention Bio, Inc.’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. 1N’26
  2. D
  3. J’27
  4. F
  5. M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 9 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Under way, not recruiting111%
  • Completed778%
  • Stopped early111%

Phase

  • Phase 24
  • Phase 13
  • Phase 31

Where

  • United States6
  • Poland3
  • Canada3
  • Germany3
  • Ukraine2
  • Belgium2

Over the years

  1. 18
  2. 19
  3. 420
  4. 21
  5. 22
  6. 23
  7. 24
  8. 25
  9. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Provention Bio, Inc.5 studies
  • Provention Bio, a Sanofi Company4 studies

Something wrong with this grouping? Tell us on the Sanofi page.

Studies

Recruiting first, then most recently updated. Showing 9 of 9. All Sanofi studies →